| +0.18 / +0.55%|
The 13 analysts offering 12-month price forecasts for Thoratec Corp have a median target of 31.00, with a high estimate of 36.00 and a low estimate of 24.00. The median estimate represents a -5.46% decrease from the last price of 32.79.
The current consensus among 16 polled investment analysts is to Hold stock in Thoratec Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.